GAVIR is a synthetic nucleoside analogue that inhibits viral DNA synthesis, effectively preventing replication of herpesviruses, especially cytomegalovirus. It is indicated in cases where oral therapy is insufficient or rapid systemic control is required.
Recommended for:
CMV infections in HIV/AIDS patients
CMV prophylaxis after organ transplantation
Herpesvirus infections in immunocompromised individuals
Severe Epstein-Barr virus infections
CMV retinitis treatment
CMV infection prophylaxis post-transplant
Severe systemic herpes infections
Epstein-Barr virus-related infections
The powder should be reconstituted just before use and administered via intravenous infusion. Dosage and treatment duration are determined by a physician based on renal function, body weight, and patient’s condition.
Hypersensitivity to ganciclovir or acyclovir
Severe neutropenia or thrombocytopenia
Pregnancy and breastfeeding
Paediatric use unless prescribed
Anaemia, leukopenia, thrombocytopenia
Gastrointestinal symptoms (nausea, diarrhoea)
Headache, confusion
Elevated creatinine levels
Infusion site reactions
Rare: seizures, hallucinations
